Register and share your invite link to earn from video plays and referrals.

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
Joined November 2024
109 Following    32K Followers
Samsung Biologics' $2 billion rights offering was oversubscribed more than five times, drawing bids for 11.9 million shares against 2.3 million offered. The proceeds help fund its acquisition of PolyPeptide, per Dow Jones.
Show more